Ultrastructure of the trabecular meshwork in secondary glaucoma eyes after intravitreal triamcinolone acetonide

Journal of Glaucoma

Volumn 15, Issue 2, 2006, Pages 117-119

  Kubota, Toshiaki ^a   Okabe, Hakuoh ^b   Hisatomi, Toshio ^c   Yamakiri, Keita ^b   Sakamoto, Taiji ^b   Tawara, Ahihiko ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Extracellular matrix; Secondary glaucoma; Trabecular meshwork; Triamcinolone acetonide

Indexed keywords

KENAKORT A; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CASE REPORT; CATARACT EXTRACTION; CILIARY DISK; CORTICOSTEROID THERAPY; EXTRACELLULAR MATRIX; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE; LENS IMPLANT; MALE; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; SECONDARY GLAUCOMA; TRABECULAR MESHWORK; TRABECULECTOMY; ULTRASTRUCTURE; UVEITIS; VITRECTOMY;

EXTRACELLULAR MATRIX; FEMALE; GLAUCOMA; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; TRABECULAR MESHWORK; TRABECULECTOMY; TRIAMCINOLONE ACETONIDE; UVEITIS; VITREOUS BODY;

EID: 33646798422     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200604000-00007     Document Type: Article

References (14)

1. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 2003;87:24-27.
2. Jonas JB, Kreissig I, Degenring R. Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol. 2003;121:729-730.
3. Smithen LM, Ober MD, Maranan L, et al. Intravireal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol. 2004;138:740-743.
4. Kayes J, Becker B. The human trabecular meshwork in steroid-induced glaucoma. Trans Am Ophthalmol Soc. 1969;67:9-54.
5. Rohen JW, Linner E, Witmer R. Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid glaucoma. Exp Eye Res. 1973;17:19-31.
6. Johnson D, Gottanka J, Flugel C, et al. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol. 1997;115:375-383.
7. Clark AF, Steely HT, Dickerson JE Jr, et al. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci. 2001;42:1769-1780.
8. Clark AF, Wilson K, McCartney MD, et al. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1994;35:281-294.
9. Fautsch MP, Bahler CK. Recombinant TIGR/MYOC increases outflow resistance in the human anterior segment. Invest Ophthalmol Vis Sci. 2000;41:4163-4168.
10. Polansky JR. HTM cell culture model for steroid effects on intraocular pressure: overview. In: Luetjen-Drecoll E, ed. Basic Aspects of Glaucoma Research III. Stuttgart: Schattauer; 1993:307-318.
11. Nguyen TD, Chen P, Huang WD, et al. Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Bio Chem. 1998;273:6341-6350.
12. Tamm ER, Russell P, Epstein DL, et al. Modulation of myocilin/TIGR expression in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1999;40:2577-2582.
13. Wang X, Johnson D. mRNA in situ hybridization of TIGR/MYOC in human trabecular meshwork. Invest Ophthalmol Vis Sci. 2000;41:1724-1729.
14. Jacobson N, Andrews M, Shepard AR, et al. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet. 2001;10:117-125.